Category: biologic
Aliases: Simponi, Simponi Aria, anti-TNFα mAb
Fully human IgG1κ mAb generated by transgenic mouse platform, binds both soluble and transmembrane TNFα. Monthly SC dosing improves adherence vs adalimumab q2w. Once-monthly cadence makes golimumab attractive for patients with stable disease.
SC: 288h, IV: 288h